Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovateltide in Acute Ischemic Stroke
NCT04047563Phase 3Completed
- Sponsor
- Pharmazz, Inc.
- Start
- Nov 2019
- Primary completion
- Feb 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sovateltide in ischemic stroke, sponsored by Pharmazz, Inc.. Started Nov 2019; status: completed.
02
Drugs
sovateltide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04047563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04047563.